Delivery Order SPE2DB22D2206-SPE2DB24FGV01

Award Date 4/23/24
Potential Completion Date 4/24/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,556 units of Lisinopril-HCTZ 20-12.5 mg tablets in 1,000 count bottles. The $1,418.22 firm-fixed price delivery order has an ultimate completion date of August 26, 2024. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for supplying a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Lisinopril-HCTZ 20-25 mg. The single-award, firm-fixed price delivery order, valued at $2,066.47, has a completion date of July 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,116.42, is for the delivery of Lisinopril-HCTZ 20-25 mg tablets in 1,000-count units. The contract is a Firm Fixed Price Delivery Order with a period of performance running through March 14, 2025. The contract was not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for 1,000 units of the medication Lisinopril-HCTZ 20-25 mg tablets, with a potential value of $1,459.16. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
This federal contract award, valued at $4,464.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,557,446,490 units of the prescription drug Lisinopril-HCTZ 20-25 mg tablets. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,088 units of Lisinopril-HCTZ 20-25 mg tablets, with a ceiling value of $1,027.91 and a period of performance through October 15, 2024. AmerisourceBergen has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by DLA and other agencies, including a $999,999,999 IDC with DLA Troop...
This federal contract award is for the delivery of Lisinopril-HCTZ 20-12.5 mg tablets in 1,000 count sizes. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment...
Amerisourcebergen Drug Corp, through its Corporate Office division, was awarded a firm fixed price delivery order contract (SPE2DX15D1205|SPE2DX24F51J0) by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to supply 4563906279 - Lisinopril-HCTZ 10-12.5 mg tablets in 1000 count bottles. The contract has a ceiling value of $2,677.06 and a period of performance through March 11, 2024. This delivery order is part of a larger $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,654.66, is a delivery order for 4,563,436,091 tablets of the generic drug Lisinopril 10 mg. The award has an ultimate completion date of January 25, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,110,689 lisinopril 20 mg tablets in lots of 1,000. This $1,056.28 award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract with DLA to deliver pharmaceutical products and medical...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FGV01
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,661.04 firm fixed-price delivery order is for the supply of 4564374289 - Lisinopril-HCTZ 20-12.5 mg Tablets, 500 count. The award does not have a set-aside designation.

AmerisourceBergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025. This contract serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 7/23/24, 10:57 AM